-
Moderna publishes interim results from older adults in phase 1 study of its COVID-19 vaccine
expresspharma
October 10, 2020
At the 25 µg and 100 µg dose levels, mRNA-1273 was generally well-tolerated in all age cohorts, neutralizing antibody titers and T cell responses in the 56-70 and 71+ age cohorts were consistent with those reported in younger adults.
-
China’s experimental COVID-19 vaccine appears safe: study
expresspharma
October 10, 2020
The most common adverse reactions reported by the trial participants were mild pain, slight fatigue and redness, itching and swelling at the injection site.
-
Mapi Pharma Commissions Facility to Support Supply of COVID-19 Vaccines
contractpharma
October 10, 2020
Makes available its production, cold-chain and storage capacities for the delivery of vaccines to Israel and the EU.
-
Pfizer and BioNTech initiate rolling submission for Covid-19 vaccine
pharmaceutical-technology
October 10, 2020
Pfizer and BioNTech have initiated a rolling submission to the European Medicines Agency (EMA) for BNT162b2, the vaccine candidate against Covid-19.
-
COVID-19 Vaccine Trial Resumed in Japan
americanpharmaceuticalreview
October 10, 2020
The Phase I/II clinical trial for the COVID-19 vaccine AZD1222 has resumed in Japan after discussion with the Japanese Pharmaceuticals and Medical Devices Agency (PMDA).
-
Moderna will not enforce COVID-19 vaccine patents during pandemic
expresspharma
October 09, 2020
Moderna is not asserting its intellectual property rights for its vaccine technology.
-
Experts laud DCGI ruling to conduct phase II/III clinical trials of Sputnik-V in India
expresspharma
October 09, 2020
The Indian regulator has instructed Dr Reddy’s Laboratories carry out the trials of the vaccine with proper monitoring of immune response and also submit stability data as per usage conditions.
-
CDMO to conduct fill and finish manufacture of COVID-19 vaccine
europeanpharmaceuticalreview
October 09, 2020
US outsourcing organisation GRAM is set to undertake the aseptic fill and finish manufacture of J&J’s COVID-19 vaccine candidate.
-
BioNTech to Acquire GMP Manufacturing Site
americanpharmaceuticalreview
September 27, 2020
BioNTech announced the signing of a share purchase agreement with Novartis AG, Basel / Switzerland to acquire their GMP certified manufacturing facility in Marburg, Germany.
-
Serum Institute of India: outsourced manufacturing of COVID-19 vaccines
europeanpharmaceuticalreview
September 27, 2020
As the COVID-19 pandemic and the search for an effective preventative vaccine continues, the Serum Institute of India has entered into manufacturing agreements with both Novavax and Codagenix to help supply their experimental COVID-19 vaccine candidates.